Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 2535-2544

  Liao, Chen ^a   Xiao, Wei ^a   Zhu, Nuo ^a   Liu, Zhiyuan ^a   Yang, Jiu ^a   Wang, Yanhu ^a   Hong, Mei ^a  

^a NANJING CHEST HOSPITAL   (China)

Author keywords

CCL 22; CD4+CD25+ T regulator cells; Lewis lung cancer cells; MiR 545; Radiotherapy; Tumor xenograft

Indexed keywords

CCL22 PROTEIN, MOUSE; MACROPHAGE DERIVED CHEMOKINE; MICRORNA;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CARCINOMA, LEWIS LUNG; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MOUSE; RADIATION RESPONSE; RADIATION TOLERANCE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CHEMOKINE CCL22; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; MICRORNAS; RADIATION TOLERANCE; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSFECTION; UP-REGULATION;

EID: 84933035306     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Esposito L, Conti D, Ailavajhala R, Khalil N and Giordano A. Lung cancer: are we up to the challenge? Curr Genomics 2010; 11: 513-518.
2. Gupta A, Probst HC, Vuong V, Landshammer A, Muth S, Yagita H, Schwendener R, Pruschy M, Knuth A and van den Broek M. Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J Immunol 2012; 189: 558-566.
3. Roses RE, Xu M, Koski GK and Czerniecki BJ. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer. Oncogene 2008; 27: 200-207.
4. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L and Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
5. Ahmed MM, Guha C, Hodge JW and Jaffee E. Immunobiology of radiotherapy: new paradigms. Radiat Res 2014; 182: 123-125.
6. Wing K, Fehervari Z and Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol 2006; 18: 991-1000.
7. Menetrier-Caux C, Curiel T, Faget J, Manuel M, Caux C and Zou W. Targeting regulatory T cells. Target Oncol 2012; 7: 15-28.
8. Zhou G and Levitsky HI. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J Immunol 2007; 178: 2155-2162.
9. Ladoire S, Martin F and Ghiringhelli F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 2011; 60: 909-918.
10. Nizar S, Copier J, Meyer B, Bodman-Smith M, Galustian C, Kumar D and Dalgleish A. T-regulatory cell modulation: the future of cancer immunotherapy? Br J Cancer 2009; 100: 1697-1703.
11. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295-307.
12. von Herrath MG and Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3: 223-232.
13. Levings MK, Sangregorio R and Roncarolo MG. Human cd25 (+) cd4 (+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193: 1295-1302.
14. Schreiber H, Wu TH, Nachman J and Kast WM. Immunodominance and tumor escape. Semin Cancer Biol 2002; 12: 25-31.
15. Bernstein MB, Garnett CT, Zhang H, Velcich A, Wattenberg MM, Gameiro SR, Kalnicki S, Hodge JW and Guha C. Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions. Cancer Biother Radiopharm 2014; 29: 153-161.
16. Bhattacharyya S, Deb J, Patra AK, Thuy Pham DA, Chen W, Vaeth M, Berberich-Siebelt F, Klein-Hessling S, Lamperti ED, Reifenberg K, Jellusova J, Schweizer A, Nitschke L, Leich E, Rosenwald A, Brunner C, Engelmann S, Bommhardt U, Avots A, Muller MR, Kondo E and Serfling E. NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network. J Exp Med 2011; 208: 823-839.
17. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Chen L and Zou W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 9: 562-567.
18. Taylor PA, Noelle RJ and Blazar BR. CD4 (+) CD25 (+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318.
19. van Maurik A, Herber M, Wood KJ and Jones ND. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002; 169: 5401-5404.
20. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
21. Du B, Wang Z, Zhang X, Feng S, Wang G, He J and Zhang B. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells. PLoS One 2014; 9: e88022.
22. Cellini F, Morganti AG, Genovesi D, Silvestris N and Valentini V. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. Molecules 2014; 19: 5379-5401.
23. Khong HT and Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002; 3: 999-1005.